tiprankstipranks
Trending News
More News >
Tryptamine Therapeutics Limited (AU:TYP)
ASX:TYP
Australian Market

Tryptamine Therapeutics (TYP) Income Statement

Compare
14 Followers

Tryptamine Therapeutics Income Statement

Last quarter (Q4 2022), Tryptamine Therapeutics's total revenue was $―, a decrease of ― from previous quarter. In Q4, Tryptamine Therapeutics's net income was $―. See Tryptamine Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 22Jun 21Jun 20Jun 19
Total Revenue
$ ―$ ―$ ―$ ―
Gross Profit
$ 99.73K$ ―$ 2.62M$ ―
Operating Expenses
$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.73M$ 1.01M$ 382.42K$ ―
EBITDA
$ -8.27M$ -11.66M$ -7.62M$ -2.31M
Operating Income
$ -14.11M$ -12.67M$ -8.00M$ -2.31M
Other Income/Expenses
$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―
Net Income
$ -10.08M$ -8.47M$ -5.28M$ -2.28M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Tryptamine Therapeutics Earnings and Revenue History